产品编号:GM-87870MAB
产品名称:Anti-IL-12/23(p40) hIgG1 Reference Antibody (Ustebio)
目录价:询价

产品编号:GM-87870MAB
产品名称:Anti-IL-12/23(p40) hIgG1 Reference Antibody (Ustebio)
目录价:询价

GM-87870MAB-1mg / 1 mg
GM-87870MAB-5mg / 5 mg
GM-87870MAB-25mg / 25 mg
GM-87870MAB-50mg / 50 mg
GM-87870MAB-100mg / 100 mg
Expression System  | CHO  | 
Aggregation  | < 5% as determined by SEC-HPLC  | 
Purity  | > 95% as determined by SDS-PAGE  | 
Endotoxin  | < 1 EU/mg, determined by LAL gel clotting assay  | 
Sterility  | 0.2 μm Filtered  | 
Target  | IL-12& IL-23  | 
Clone  | Ustekinumab  | 
Source/Isotype  | Monoclonal Human IgG1, Kappa  | 
Application  | Bioactivity-ELISA; Block assay  | 
Description  | Ustekinumab (brand name: Stelara) is a fully human IgG1κ monoclonal antibody developed by Janssen Biotech, a subsidiary of Johnson & Johnson. It is used to treat various immune-mediated diseases, such as psoriasis, psoriatic arthritis, and Crohn's disease. It exerts its immunomodulatory effects by specifically inhibiting the activity of the pro-inflammatory cytokines IL-12 and IL-23.  | 
Formulation  | phosphate-buffered solution, pH 7.2-7.4.  | 







产品编号:GM-87870MAB
产品名称:Anti-IL-12/23(p40) hIgG1 Reference Antibody (Ustebio)
目录价:询价

GM-87870MAB-1mg / 1 mg
GM-87870MAB-5mg / 5 mg
GM-87870MAB-25mg / 25 mg
GM-87870MAB-50mg / 50 mg
GM-87870MAB-100mg / 100 mg
Expression System  | CHO  | 
Aggregation  | < 5% as determined by SEC-HPLC  | 
Purity  | > 95% as determined by SDS-PAGE  | 
Endotoxin  | < 1 EU/mg, determined by LAL gel clotting assay  | 
Sterility  | 0.2 μm Filtered  | 
Target  | IL-12& IL-23  | 
Clone  | Ustekinumab  | 
Source/Isotype  | Monoclonal Human IgG1, Kappa  | 
Application  | Bioactivity-ELISA; Block assay  | 
Description  | Ustekinumab (brand name: Stelara) is a fully human IgG1κ monoclonal antibody developed by Janssen Biotech, a subsidiary of Johnson & Johnson. It is used to treat various immune-mediated diseases, such as psoriasis, psoriatic arthritis, and Crohn's disease. It exerts its immunomodulatory effects by specifically inhibiting the activity of the pro-inflammatory cytokines IL-12 and IL-23.  | 
Formulation  | phosphate-buffered solution, pH 7.2-7.4.  | 






